ÂÜÀòÂÒÂ×

Erik van Duijn possesses extensive experience in the field of psychiatry and medical research, currently serving as a psychiatrist at Thalatta since February 2018. Additional roles include board member of Zonnehuisgroep Amstelland and chair of the Vereniging van Zelfstandig Gevestigde Psychiaters Kennemerland since 2022. Erik van Duijn has been a policy advisor for Huntington's disease at Topaz and a judicial expert at the Nederlands Register Gerechtelijk Deskundigen since 2010. Furthermore, Erik van Duijn has a significant role as a clinical researcher at Leiden University Medical Center since 2004 and has held various advisory and oversight positions across multiple healthcare institutions. Erik van Duijn earned a PhD in Medicine from Leiden University.